Tag

Hormone Therapy

All articles tagged with #hormone therapy

health2 days ago•4 min saved

Early menopause linked to higher Alzheimer’s risk in women, study finds

A study of more than 2,600 women published in JAMA Network Open links earlier menopause (natural or surgical) to faster brain aging and an earlier Alzheimer’s diagnosis decades later, with white-matter changes implicated; the timing of menopause may be influenced by other health factors, though estrogen-only hormone therapy was associated with about a 35% lower lifetime risk, and surgical menopause can cause abrupt hormonal shifts affecting cognition.

via New York Post|

#alzheimers-disease #brain-aging #health

health13 days ago•7 min saved

Menopause Hormone Therapy May Lower Alzheimer's Pathology, Stanford Study Shows

A Stanford Neurology study analyzing post-mortem and living participants found estrogen-only menopausal hormone therapy is associated with about a 35% lower risk of Alzheimer's pathology and 39% lower odds of dementia, with living users showing better memory and function. The work suggests possible neuroprotective effects of estrogen and potential greater benefit if started near menopause, but as an observational study it cannot prove causation, and randomized trials are needed to confirm brain-health benefits.

via Fox News|

#alzheimers-disease #estrogen #health

health14 days ago•5 min saved

Estrogen-Only Menopause Therapy Linked to Lower Alzheimer's Risk, Study Finds

A Stanford-led analysis of brain autopsies from about 21,000+ women found that estrogen-only menopause hormone therapy was associated with roughly a 35% lower lifetime risk of Alzheimer's disease compared with non-users, suggesting a modest protective brain effect for some women. The study notes this is associative, not proof of causation, and results do not necessarily apply to estrogen-plus-progestin or topical forms; benefits may be most relevant to women who started therapy near menopause and who had hysterectomies.

via New York Post|

#alzheimers-disease #brain-health #estrogen

health29 days ago•6 min saved

Rethinking Menopausal Hormone Therapy: From Flawed Fears to Tailored Care for Survivors

Fear of menopausal hormone therapy stemmed from the WHI and HABITS trials, leading to underuse, especially among breast cancer survivors. New analyses highlight inconsistencies and limitations in those studies, and the FDA's 2025 removal of the black box warning signals a need for personalized risk–benefit discussions. The article advocates shared decision-making and precision medicine to determine when and for whom menopausal hormone therapy may be appropriate, rather than applying a blanket restriction.

via The Conversation|

#breast-cancer #guidelines #health

defense1 month ago•8 min saved

Pentagon’s Testosterone Push Faces VA Care Gaps and Fertility Concerns

The Pentagon’s plan to screen and treat testosterone in service members—despite doctors warning against universal screening—risks repeating VA’s past failures in testosterone replacement, may drive unnecessary therapy, threaten fertility, and complicate care when service members transition to veterans benefits, all amid limited coverage for infertility under TRICARE.

via The Intercept|

#defense #fertility #hormone-therapy

health1 month ago•10 min saved

Early, targeted therapies reshape outcomes in metastatic prostate cancer

Advances in metastatic prostate cancer—earlier use of combination hormone therapy, targeted drugs, improved imaging with PSMA PET, and newer treatments like radioligand therapy and PARP inhibitors for eligible mutations—are extending survival. Biden’s case highlights how personalized, multidisciplinary care can manage the disease even when it has spread to bones and other organs. While outcomes vary by tumor biology and patient health, most men can live longer with fewer but meaningful side effects, though bone health and quality-of-life considerations remain important.

via CNN|

#health #hormone-therapy #metastatic-cancer

health1 month ago•5 min saved

Menopause Hormone Therapy: what it can help with, what it can’t, and how to decide

MHT can relieve hot flashes, night sweats, sleep issues, and reduce fracture risk for many women started within 10 years of their last period or before 60, especially with transdermal or local estrogen. But hype and misinformation—like claims it prevents dementia or cures aging—are widespread, and not all symptoms are due to menopause. A careful, evidence-based evaluation by a clinician is essential to determine if MHT is right for you.

via The Guardian|

#health #hormone-therapy #menopause

military1 month ago•12 min saved

Pentagon Rolls Out Testosterone Screening for Troops, Stirring Health Debate

The DoD announced annual testosterone screening for service members over 30 to optimize fitness, with younger personnel allowed to opt in; experts warn the policy could lead to misdiagnoses, overprescribing, and health risks from testosterone therapy, since evidence that higher T improves performance in under-50s is weak and sleep or training factors can skew results. The program relies on a health questionnaire rather than a full exam, and critics argue it overlooks women’s hormonal health while prioritizing “high T” goals over fundamentals like sleep, nutrition, and training.

via Business Insider|

#defense #health-policy #hormone-therapy

health2 months ago•6 min saved

Menopause hormone therapy appears to guard against bone thinning in new study

A retrospective cohort study of 387 postmenopausal women presented at ENDO 2026 found those using menopausal hormone therapy had 69% lower odds of low bone mineral density than non-users (31.8% vs 56.2%), with higher lumbar spine and total hip T-scores, suggesting MHT may protect against osteoporosis. The study is observational and not peer‑reviewed, and regimens varied; risks such as uterine cancer, heart attack, stroke, and breast cancer should be weighed, with decisions individualized.

via Medical News Today|

#bone-density #endo-2026 #health

health2 months ago•137 min saved

Menopause Hormone Therapy Demand Surges, Training Gaps Persist

Rising awareness and positive long-term data have boosted demand for menopause hormone therapy (MHT), with body-identical estrogens and progestogens used to relieve symptoms and support bone health. Yet supply shortages continue and gaps in research and clinician training linger, including limited menopause education in UK/US curricula. In New Zealand, online menopause-care training for health workers has been developed and advocates are calling for more funded MHT options and NZ-specific data on users’ experiences and outcomes.

via 1News|

#health #hormone-therapy #menopause

health2 months ago•13 min saved

Menopause, memory, and the timing of care: crucial conversations in your fifties

A growing body of evidence shows cognitive symptoms during the menopausal transition are real and linked to estrogen loss that reduces gray matter in memory-related brain regions; studies like SWAN suggest perimenopausal cognitive decline may be reversible after menopause, emphasizing the need for earlier, routine conversations about brain health and hormone therapy, whose benefits on memory appear to depend on timing, though findings are still debated and decisions should be individualized.

via Space Daily|

#brain-health #health #hormone-therapy

health2 months ago•2 min saved

Hormone combo around surgery may redefine care for high-risk prostate cancer

A phase 3 PROTEUS trial shows that administering two hormone therapies both before and after prostate cancer surgery improves outcomes versus a single hormone therapy in high-risk, early-stage patients, a result that some doctors see as paving the way for a potential new standard of care.

via statnews.com|

#cancer-research #health #hormone-therapy

health4 months ago•177 min saved

The menopause product boom meets medical skepticism

A surge of menopause-focused products—ranging from skincare and dietary supplements to gadgets and wearable prompts—has flooded markets and social media. Doctors warn that many claims aren’t scientifically proven and advise patients to discuss evidence-based options with their clinicians, such as hormone therapy (when appropriate), nonhormonal medications, and lifestyle measures like regular exercise and a healthy diet. Dermatologists also stress sensible skincare and sun protection, noting that some beauty claims (e.g., ingestible collagen) lack solid science.

via CNN|

#advertising #consumer-products #health

health5 months ago•10 min saved

Living with Prostate Cancer: PSA testing, treatment hurdles, and a UK screening debate

UK men face rising prostate cancer diagnoses while a National Screening Committee says broad PSA screening isn’t justified due to risks of overdiagnosis and overtreatment, even as awareness grows and access varies by socioeconomic status. The piece follows men like Bulteel, Pennington, Walsh and Hemans, illustrating how PSA testing can detect cancer early but also lead to difficult treatment paths (surgery, radiotherapy, hormone therapy) and significant emotional and relational strain, highlighting disparities in access and the push for targeted screening for at‑risk groups.

via The Guardian|

#health #health-inequality #hormone-therapy

health5 months ago•5 min saved

Biomarker may flag dementia risk for certain menopause hormone therapies

New analysis of WHI data finds that higher baseline plasma p-tau217, an Alzheimer's biomarker, is linked to a substantially higher dementia risk, especially for women on combined estrogen–progesterone therapy started later in life; estrogen-only therapy did not show the same pattern. The risk was strongest among women over 70, white women, and APOE4 carriers, suggesting hormone interactions with brain vulnerability rather than a direct cause. Starting combined hormone therapy around menopause for five years or less generally does not raise dementia risk, but starting after 65 may for some women. Biomarkers like p-tau217 could help identify who is most at risk.

via The Conversation|

#apoe4 #dementia #health